Becton Dickinson Licensing Deals Under Scrutiny

Law360, New York (April 25, 2007, 12:00 AM EDT) -- Becton Dickinson and Co. is facing arbitration and dispute resolution proceedings in Europe initiated by a French medical testing company over staph infection detection and blood culturing patents, the medical technology giant announced Wednesday.

In a letter received by Becton Dickinson on Tuesday, French company bioMérieux SA said it had initiated an arbitration proceeding with the ICC International Court of Arbitration in Paris against BD subsidiary GeneOhm Sciences Canada. bioMérieux wants to terminate a sublicense agreement in which it granted GeneOhm rights to a method for...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.